Experts Recommend Changes for Colorectal Screening Access and Quality

State-of-Science LogoThe first priority of an expert panel looking at increasing the number of people being screened for colorectal cancer was to “Eliminate financial barriers to colorectal cancer screening and appropriate follow up.”

Meeting for two days in Washington in February, a National Institutes of Health State-of-the-Science conference considered what is known– and not known– about why people choose or avoid screening, how to improve screening quality, and what the healthcare capacity is to deliver colorectal cancer screening to the US population.

At the end of the meeting, the panel released a consensus statement with their recommendations for enhancing the use and quality of colorectal cancer screening.

While the panel found that colorectal cancer screening rates were increasing, they still remain too low.  Rates moved from 20 to 30 percent of eligible people in 1997 to 55 percent in 2008, leaving millions of the population unscreened by any method.

To close the gap in screening, the panel identified the following priorities:

In addition to underuse of screening, the panel found situations of overuse:  colonoscopies performed more often than guidelines recommend or patients with serious illness or limited life expectancy being screened without possible benefit.

They also identified misuse of screening when FOBT screening was done in an office setting rather using the recommended home tests.

The most important patient factors in getting screened, the panel discovered, were having insurance and having a usual source of medical care.  Higher income and socioeconomic levels also contributed to being screened.  Although there were lower rates of screening for African Americans and Hispanics, these disparities almost disappeared when insurance and socioeconomic factors were considered.

A recommendation from a physician was the only physician-related factor found that improved screening.  Practices that had electronic medical record reminder systems, staff who could facilitate follow-up arrangements, and patient navigators were the most successful in getting their patients screened.

Two healthcare systems had high screening rates.  Kaiser Permanente achieved a 75 percent screening rate for their Medicare patients, and the Veterans Administration system screens 75 percent of their eligible patients.  Both systems mail FOBT kits directly to patients, use focused reminders, and carefully follow-up all positive tests with colonoscopies.

The panel was concerned about capacity for colonoscopies, particularly for following up positive FOBT results.  They wrote:

Because it is unlikely that current capacity is sufficient for strategies other than universal FOBT screening, expansion of endoscopic capacity may be needed. A first step may be to examine the feasibility of increasing productivity or efficiency of existing facilities. Expanding high-quality endoscopy training to more providers, including nonphysicians, may also be warranted. Such expansion would require careful consideration of quality and patient satisfaction. Also needed is evaluation of the role of incentives, disincentives, and third-party payment policies for performing endoscopy.

In conclusion, the State-of-the-Science Panel wrote,

The panel found that despite substantial progress toward higher colorectal cancer screening rates nationally, screening rates fall short of desirable levels. Targeted initiatives to improve screening rates and reduce disparities in underscreened communities and population subgroups could further reduce colorectal cancer morbidity and mortality. This could be achieved by utilizing the full range of screening options and evidence-based interventions for increasing screening rates. With additional investments in quality monitoring, Americans could be assured that all screening achieves high rates of cancer prevention and early detection.

Bookmark and Share

This news article was originally posted on February 24th, 2010 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on February 24th, 2010
Tags: colonoscopy, colorectal cancer screening, FOBT

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe